// App-Quantinova.ai

TCT-140 : Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study.

Researchers

Presenter

  • Jose M De la Torre Hernandez

Principal Investigators

  • Juan F Oteo Dominguez

  • Felipe Hernandez

  • Omar Abdul-Jawad Altisent

  • Fernando Rivero-Crespo

  • Jose D Cascon

  • Antonio L Arrebola

  • Federico Gimeno

  • German Zavala

Medical Centers

  • Hospital Universitario Virgen de las Nieves, Granada, Spain

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • H. Clinico de Tenerife, Santa Cruz de Tenerife, Spain

  • University Hospital Vall d'Hebron, Barcelona, Spain

  • Terrassa Hospital, Terrassa, Spain

  • Insitut German Trials i Pujol, Badalona, Spain

  • Pharmacy, Hospital Juan Ramon Jimenez, Huelva, Spain

  • de Octubre, Madrid,Spain

  • Hospital Del Mar, Barcelona, Spain

  • Hospital de Basurto, Basurto, Spain

  • Hospital Clinico Universitario de Valladolid, Valladolid, Spain

  • Hospital Carlos Haya, Malaga, Spain

  • Hospital de Santa Lucia, Cartagena, Spain

  • Hospital Virgen de la Victoria, Malaga, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Puerta de Hierro, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Coronary Artery Disease

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Promus Element

  • Everolimus

  • Umirolimus

  • Crofelemer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved